• Citer

Responsiveness to recombinant erythropoietin therapy in end-stage renal disease. An analysis of the predictive value of several biological measurements, including circulating erythroid progenitors.

par Corazza, Francis ;Bergmann, Pierre ;Dratwa, Max ;Guns, Martine ;Fondu, Pierre
Référence Nephrology, dialysis, transplantation, 7, 4, page (311-317)
Publication Publié, 1992

Article révisé par les pairs

• Détails
• Contenu

Titre:	Responsiveness to recombinant erythropoietin therapy in end-stage renal disease. An analysis of the predictive value of several biological measurements, including circulating erythroid progenitors.
Auteur:	Corazza, Francis; Bergmann, Pierre; Dratwa, Max; Guns, Martine; Fondu, Pierre
Informations sur la publication:	Nephrology, dialysis, transplantation, 7, 4, page (311-317)
Statut de publication:	Publié, 1992
Sujet CREF:	Endocrinologie
	Médecine clinique [biologie clinique]
	Médecine pathologie humaine
MeSH keywords:	Adult
	Aged
	Anemia -- blood -- drug therapy -- etiology
	Erythrocyte Count
	Erythroid Precursor Cells -- drug effects
	Erythropoietin -- administration & dosage -- therapeutic use
	Female
	Hemoglobins -- metabolism
	Humans
	Kidney Failure, Chronic -- blood -- complications -- drug therapy
	Male
	Middle Aged
Note générale:	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0931-0509
	info:pmid/1317521